Current
10.2×
5-Year Average
11.8×
All-Time High
21.4×
All-Time Low
2.0×
P/S Ratio daily chart for IDEXX Laboratories (IDXX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for IDEXX Laboratories (IDXX) from 2001 to 2025
| 2025 | $54.19B | $4.30B | 12.6× | +3.9× | |
| 2024 | $33.84B | $3.90B | 8.7× | -3.9× | |
| 2023 | $46.12B | $3.66B | 12.6× | +2.5× | |
| 2022 | $33.83B | $3.37B | 10.0× | -7.3× | |
| 2021 | $55.86B | $3.22B | 17.4× | +1.6× | |
| 2020 | $42.73B | $2.71B | 15.8× | +6.5× | |
| 2019 | $22.42B | $2.41B | 9.3× | +2.1× | |
| 2018 | $16.07B | $2.21B | 7.3× | +0.3× | |
| 2017 | $13.67B | $1.97B | 6.9× | +1.0× | |
| 2016 | $10.47B | $1.78B | 5.9× | +1.8× | |
| 2015 | $6.62B | $1.60B | 4.1× | -0.6× | |
| 2014 | $7.08B | $1.49B | 4.8× | +0.8× | |
| 2013 | $5.53B | $1.38B | 4.0× | +0.1× | |
| 2012 | $5.08B | $1.29B | 3.9× | +0.4× | |
| 2011 | $4.25B | $1.22B | 3.5× | -0.1× | |
| 2010 | $3.98B | $1.10B | 3.6× | +0.6× | |
| 2009 | $3.10B | $1.03B | 3.0× | +0.9× | |
| 2008 | $2.13B | $1.02B | 2.1× | -1.8× | |
| 2007 | $3.57B | $922.55M | 3.9× | +0.5× | |
| 2006 | $2.47B | $739.12M | 3.3× | -0.2× | |
| 2005 | $2.29B | $638.10M | 3.6× | +0.3× | |
| 2004 | $1.80B | $549.18M | 3.3× | -0.1× | |
| 2003 | $1.61B | $475.99M | 3.4× | +0.7× | |
| 2002 | $1.10B | $412.67M | 2.7× | +0.2× | |
| 2001 | $966.00M | $386.08M | 2.5× | — |
- 202512.6×
- 20248.7×
- 202312.6×
- 202210.0×
- 202117.4×
- 202015.8×
- 20199.3×
- 20187.3×
- 20176.9×
- 20165.9×
- 20154.1×
- 20144.8×
- 20134.0×
- 20123.9×
- 20113.5×
- 20103.6×
- 20093.0×
- 20082.1×
- 20073.9×
- 20063.3×
- 20053.6×
- 20043.3×
- 20033.4×
- 20022.7×
- 20012.5×
About P/S Ratio at IDEXX Laboratories (IDXX)
IDEXX Laboratories (IDXX) P/S ratio is 10.2× as of June 5, 2026. The 5-year average is 11.8×. The sector median currently stands at 3.5×. The current ratio is at the 23th percentile of its own 10-year history.
IDEXX Laboratories (IDXX) historical P/S ratio has ranged from a low of 2.0× (2009) to a high of 21.4× (2021) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
IDEXX Laboratories P/S Ratio by Year
IDEXX Laboratories P/S Ratio 2025: 12.6×
IDEXX Laboratories (IDXX) P/S ratio in 2025 was 12.6×, expanded from 8.7× the prior year.
IDEXX Laboratories P/S Ratio 2024: 8.7×
IDEXX Laboratories (IDXX) P/S ratio in 2024 was 8.7×, contracted from 12.6× the prior year.
IDEXX Laboratories P/S Ratio 2023: 12.6×
IDEXX Laboratories (IDXX) P/S ratio in 2023 was 12.6×, expanded from 10.0× the prior year.
IDEXX Laboratories P/S Ratio 2022: 10.0×
IDEXX Laboratories (IDXX) P/S ratio in 2022 was 10.0×, contracted from 17.4× the prior year.
IDEXX Laboratories P/S Ratio 2021: 17.4×
IDEXX Laboratories (IDXX) P/S ratio in 2021 was 17.4×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of IDEXX Laboratories (IDXX), ranked by P/S ratio.
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric